Independent Director · Denali Therapeutics Inc. (DNLI)

Chair, Audit Committee

Peter Klein director compensation at Denali Therapeutics: $319K

Fiscal year 2025 director compensation for Peter Klein at Denali Therapeutics Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 21, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Peter Klein’s full pay file as a PDF — free

More than this page: up to 10 years of Peter’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Peter Klein and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Denali Therapeutics Director Compensation Table · all 3 fiscal years held
In US dollars, as Denali Therapeutics reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$77,500$84,095$157,285$0$318,880
FY2022$65,000$145,280$257,821—$468,101
FY2021$60,000$132,238$220,617—$412,855

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Denali Therapeutics Inc. DEF 14A filed April 21, 2026, accession 0001714899-26-000054, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Denali Therapeutics Inc. filed document, accession 0001714899-26-000054. Every figure is read from that document and cited to the page and table it appears in. Filed April 21, 2026.

Get the Denali Therapeutics Board Governance Report

$318,880 Peter Klein, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 21, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

Committees

FY2025 · as the proxy prints them

Audit (Chair) · Compensation

The rest of the Denali Therapeutics board

FY2025 · as the company reported each
DirectorRoleFY2025 total
David Schenkein, M.DIndependent Director$311,380
Jay FlatleyIndependent Director$316,380
Jennifer CookIndependent Director$301,380
Julian C. BakerChair of the Board$474,348
Nancy A. ThornberryIndependent Director$306,380
Ryan J. Watts, Ph.DDirector—
Steve E. KrognesIndependent Director$297,149
Tim Van HauwermeirenIndependent Director$467,961

The full Denali Therapeutics compensation record

free company brief

This page is one director within Denali Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Denali Therapeutics proxy · each links to its own free brief

Order DNLI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report